|
|
Volumn 99, Issue 5, 2015, Pages 618-623
|
|
One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RANIBIZUMAB;
TRIAMCINOLONE ACETONIDE;
ANGIOGENESIS INHIBITOR;
DELAYED RELEASE FORMULATION;
GLUCOCORTICOID;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
VEGFA PROTEIN, HUMAN;
ADULT;
AGE RELATED MACULAR DEGENERATION;
AGED;
ARTICLE;
CATARACT;
CLINICAL ARTICLE;
COMBINATION CHEMOTHERAPY;
CONJUNCTIVAL HEMORRHAGE;
DRUG ADMINISTRATION ROUTE;
DRUG EFFICACY;
DRUG MIXTURE;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
INJECTION SITE BLEEDING;
INTRAOCULAR HYPERTENSION;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT;
PATIENT COMPLIANCE;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
RETREATMENT;
SINGLE DRUG DOSE;
SUBFOVEAL NEOVASCULAR AGE RELATED MACULAR DEGENERATION;
SUSTAINED RELEASE FORMULATION;
TREATMENT DURATION;
VERY ELDERLY;
ANTAGONISTS AND INHIBITORS;
CASE REPORT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DELAYED RELEASE FORMULATION;
DRUG COMBINATION;
FOLLOW UP;
INTRAVITREAL DRUG ADMINISTRATION;
OPTICAL COHERENCE TOMOGRAPHY;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
VISUAL ACUITY;
WET MACULAR DEGENERATION;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
DELAYED-ACTION PREPARATIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GLUCOCORTICOIDS;
HUMANS;
INTRAVITREAL INJECTIONS;
MALE;
MIDDLE AGED;
TOMOGRAPHY, OPTICAL COHERENCE;
TRIAMCINOLONE ACETONIDE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
WET MACULAR DEGENERATION;
|
|
EID: 84928197610
PISSN: 00071161
EISSN: 14682079
Source Type: Journal
DOI: 10.1136/bjophthalmol-2014-306002 Document Type: Article |
|
Times cited : (23)
|
|
References (11)
|
